Silverarc Capital Management’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-218,975
Closed -$5.17M 99
2023
Q4
$5.17M Sell
218,975
-371,025
-63% -$6.61M 1.6% 28
2023
Q3
$8.8M Buy
590,000
+430,000
+269% +$5.7M 3.28% 8
2023
Q2
$1.75M Buy
+160,000
New +$1.49M 0.59% 48

Other funds holding CBAY